within Pharmacolibrary.Drugs.N_NervousSystem.N06B_PsychostimulantsAgentsUsedForAdhdAndNootropics.N06BA09_Atomoxetine;

model Atomoxetine
  extends Pharmacolibrary.Drugs.ATC.N.N06BA09;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>N06BA09</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Atomoxetine is a selective norepinephrine reuptake inhibitor used primarily for the treatment of attention-deficit/hyperactivity disorder (ADHD) in children, adolescents, and adults. It is a non-stimulant medication and is approved by regulatory agencies for the treatment of ADHD.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult volunteers after single oral administration.</p><h4>References</h4><ol><li><p>Sauer, JM, et al., &amp; Witcher, JW (2005). Clinical pharmacokinetics of atomoxetine. <i>Clinical pharmacokinetics</i> 44(6) 571–590. DOI:<a href=\"https://doi.org/10.2165/00003088-200544060-00002\">10.2165/00003088-200544060-00002</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15910008/\">https://pubmed.ncbi.nlm.nih.gov/15910008</a></p></li><li><p>Todor, I, et al., &amp; Briciu, C (2015). The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite. <i>Clujul medical (1957)</i> 88(4) 513–520. DOI:<a href=\"https://doi.org/10.15386/cjmed-488\">10.15386/cjmed-488</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/26733750/\">https://pubmed.ncbi.nlm.nih.gov/26733750</a></p></li><li><p>Jung, EH, et al., &amp; Bae, JW (2020). Effects of paroxetine on the pharmacokinetics of atomoxetine and its metabolites in different CYP2D6 genotypes. <i>Archives of pharmacal research</i> 43(12) 1356–1363. DOI:<a href=\"https://doi.org/10.1007/s12272-020-01300-8\">10.1007/s12272-020-01300-8</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/33245517/\">https://pubmed.ncbi.nlm.nih.gov/33245517</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Atomoxetine;
